CLARITHROMYCIN AUROBINDO

500MG TBL FLM 21

SÚKL code 0205337
Name of the product CLARITHROMYCIN AUROBINDO 500 MG POTAHOVANÉ TABLETY
_MA_MEDICATION_DETAIL_INFO_MED_NAME i CLARITHROMYCIN AUROBINDO
Supplement 500MG TBL FLM 21
Strenght 500MG
Pharmaceutical form Film-coated tablet
Package 21
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance CLARITHROMYCIN (CLARITHROMYCINUM)
ATC group J01FA09
ATC group name KLARITHROMYCIN

Marketing authorisation information

Registration Number 15/ 297/14-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 05. 2018
MA Holder Aurobindo Pharma (Malta) Limited, Floriana
MA Holder country MALTA
Actual MA holder Aurovitas Pharma Polska Sp. z o.o., Warszawa
Actual MA holder country POLSKO

Back to list